• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

普鲁士蓝清除剂通过抑制炎症和减少氧化应激来改善肝缺血再灌注损伤。

Prussian Blue Scavenger Ameliorates Hepatic Ischemia-Reperfusion Injury by Inhibiting Inflammation and Reducing Oxidative Stress.

机构信息

Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Shanghai Engineering Research Center of Transplantation and Immunology, Shanghai, China.

出版信息

Front Immunol. 2022 May 25;13:891351. doi: 10.3389/fimmu.2022.891351. eCollection 2022.

DOI:10.3389/fimmu.2022.891351
PMID:35693813
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9174572/
Abstract

Oxidative stress and excessive inflammatory responses are the two critical mechanisms of hepatic ischemia-reperfusion injury (HIRI) encountered in many clinical settings, including following hepatectomy and liver transplantation. Effective anti-inflammatory and anti-oxidative pharmacological interventions are urgently needed to counter HIRI. The present study showed that a biocompatible Prussian blue (PB) scavenger with reactive oxygen species (ROS) scavenging and anti-inflammatory properties might be used a promising treatment for HIRI. Following intravenous administration, PB scavenger was mainly distributed in the liver, where it showed excellent ability to alleviate apoptosis, tissue injury and organ dysfunction after HIRI. PB scavenger was found to protect liver tissue by scavenging ROS, reducing neutrophil infiltration and promoting macrophage M2 polarization. In addition, PB scavenger significantly reduced oxidative stress in primary hepatocytes, restoring cell viability under oxidative stress condition. PB scavenger effectively reduced lipopolysaccharide-stimulated inflammation in RAW 264.7 cells. These findings indicate that PB scavenger may be a potential therapeutic agent for the treatment of HIRI, providing an alternative treatment for ROS-associated and inflammatory liver diseases.

摘要

氧化应激和过度炎症反应是许多临床情况下(包括肝切除和肝移植后)肝缺血再灌注损伤(HIRI)的两个关键机制。迫切需要有效的抗炎和抗氧化药理干预来对抗 HIRI。本研究表明,具有活性氧(ROS)清除和抗炎特性的生物相容性普鲁士蓝(PB)清除剂可能是治疗 HIRI 的一种有前途的方法。静脉给药后,PB 清除剂主要分布在肝脏,在那里它表现出减轻 HIRI 后细胞凋亡、组织损伤和器官功能障碍的优异能力。PB 清除剂通过清除 ROS、减少中性粒细胞浸润和促进巨噬细胞 M2 极化来保护肝组织。此外,PB 清除剂还显著降低了原代肝细胞中的氧化应激,在氧化应激条件下恢复了细胞活力。PB 清除剂有效抑制了 RAW 264.7 细胞中脂多糖刺激的炎症反应。这些发现表明,PB 清除剂可能是治疗 HIRI 的一种有前途的治疗剂,为 ROS 相关和炎症性肝病提供了一种替代治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d6b/9174572/b5d11d0e27c6/fimmu-13-891351-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d6b/9174572/34bf6c049702/fimmu-13-891351-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d6b/9174572/4960e7a0b4e2/fimmu-13-891351-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d6b/9174572/5a3f0717c8f6/fimmu-13-891351-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d6b/9174572/e46a56a31775/fimmu-13-891351-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d6b/9174572/ca7a4a9fd86d/fimmu-13-891351-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d6b/9174572/b43ce7524cab/fimmu-13-891351-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d6b/9174572/b5d11d0e27c6/fimmu-13-891351-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d6b/9174572/34bf6c049702/fimmu-13-891351-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d6b/9174572/4960e7a0b4e2/fimmu-13-891351-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d6b/9174572/5a3f0717c8f6/fimmu-13-891351-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d6b/9174572/e46a56a31775/fimmu-13-891351-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d6b/9174572/ca7a4a9fd86d/fimmu-13-891351-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d6b/9174572/b43ce7524cab/fimmu-13-891351-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d6b/9174572/b5d11d0e27c6/fimmu-13-891351-g007.jpg

相似文献

1
Prussian Blue Scavenger Ameliorates Hepatic Ischemia-Reperfusion Injury by Inhibiting Inflammation and Reducing Oxidative Stress.普鲁士蓝清除剂通过抑制炎症和减少氧化应激来改善肝缺血再灌注损伤。
Front Immunol. 2022 May 25;13:891351. doi: 10.3389/fimmu.2022.891351. eCollection 2022.
2
Chlorogenic Acid Alleviates Hepatic Ischemia-Reperfusion Injury by Inhibiting Oxidative Stress, Inflammation, and Mitochondria-Mediated Apoptosis In Vivo and In Vitro.绿原酸通过抑制氧化应激、炎症和线粒体介导的细胞凋亡减轻体内和体外肝缺血再灌注损伤。
Inflammation. 2023 Jun;46(3):1061-1076. doi: 10.1007/s10753-023-01792-8. Epub 2023 Mar 1.
3
Carbon dot nanozymes as free radicals scavengers for the management of hepatic ischemia-reperfusion injury by regulating the liver inflammatory network and inhibiting apoptosis.碳点纳米酶作为自由基清除剂通过调控肝炎症网络和抑制细胞凋亡管理肝缺血再灌注损伤。
J Nanobiotechnology. 2023 Dec 21;21(1):500. doi: 10.1186/s12951-023-02234-1.
4
Pretreatment with the ALDH2 activator Alda‑1 protects rat livers from ischemia/reperfusion injury by inducing autophagy.ALDH2 激活剂 Alda-1 通过诱导自噬保护大鼠肝脏免于缺血/再灌注损伤。
Mol Med Rep. 2020 Sep;22(3):2373-2385. doi: 10.3892/mmr.2020.11312. Epub 2020 Jul 8.
5
Myeloid Deletion of Cdc42 Protects Liver From Hepatic Ischemia-Reperfusion Injury via Inhibiting Macrophage-Mediated Inflammation in Mice.Cdc42 在髓系细胞中的缺失通过抑制巨噬细胞介导的炎症反应保护小鼠肝脏免受肝缺血再灌注损伤。
Cell Mol Gastroenterol Hepatol. 2024;17(6):965-981. doi: 10.1016/j.jcmgh.2024.01.023. Epub 2024 Feb 9.
6
Ghrelin ameliorates transformation of hepatic ischemia-reperfusion injury to liver fibrosis by blocking Smad and ERK signalling pathways, and promoting anti-inflammation and anti-oxidation effects.Ghrelin 通过阻断 Smad 和 ERK 信号通路,促进抗炎和抗氧化作用,改善肝缺血再灌注损伤向肝纤维化的转化。
Transpl Immunol. 2022 Aug;73:101597. doi: 10.1016/j.trim.2022.101597. Epub 2022 Apr 3.
7
Rehmanniae Radix Praeparata aqueous extract improves hepatic ischemia/reperfusion injury by restoring intracellular iron homeostasis.熟地黄水提物通过恢复细胞内铁平衡改善肝缺血/再灌注损伤。
Chin J Nat Med. 2024 Sep;22(9):769-784. doi: 10.1016/S1875-5364(24)60719-3.
8
Targeting NF-κB in Hepatic Ischemia-Reperfusion Alleviation: from Signaling Networks to Therapeutic Targeting.靶向 NF-κB 在肝缺血再灌注缓解中的作用:从信号网络到治疗靶点。
Mol Neurobiol. 2024 Jun;61(6):3409-3426. doi: 10.1007/s12035-023-03787-w. Epub 2023 Nov 22.
9
Activation of the PPARγ/NF-κB pathway by A-MPDA@FeO@PVP scavenging reactive oxygen species to alleviate hepatic ischemia-reperfusion injury.A-MPDA@FeO@PVP 通过清除活性氧激活 PPARγ/NF-κB 通路,减轻肝脏缺血再灌注损伤。
J Mater Chem B. 2024 Jun 12;12(23):5722-5733. doi: 10.1039/d4tb00423j.
10
Acidic Microenvironment Aggravates the Severity of Hepatic Ischemia/Reperfusion Injury by Modulating M1-Polarization Through Regulating PPAR-γ Signal.酸性微环境通过调节 PPAR-γ 信号调控 M1 极化加重肝缺血/再灌注损伤的严重程度。
Front Immunol. 2021 Jun 21;12:697362. doi: 10.3389/fimmu.2021.697362. eCollection 2021.

引用本文的文献

1
Exosomes derived from ALR-modified adipose mesenchymal stem cells mediate hepatoprotective effects on hepatic ischemia-reperfusion injury by promoting regeneration and protecting mitochondria.源自ALR修饰的脂肪间充质干细胞的外泌体通过促进再生和保护线粒体对肝缺血再灌注损伤发挥肝保护作用。
Stem Cell Res Ther. 2025 Jul 15;16(1):361. doi: 10.1186/s13287-025-04517-w.
2
Dexmedetomidine Cannot Attenuate Liver Injury and Improve Outcomes Following Laparoscopic Living Donor Hepatectomy: A Randomised Controlled Trial.右美托咪定不能减轻活体供肝腹腔镜肝切除术后的肝损伤及改善预后:一项随机对照试验
Drug Des Devel Ther. 2025 May 22;19:4263-4274. doi: 10.2147/DDDT.S524343. eCollection 2025.
3

本文引用的文献

1
Prussian Blue Nanozyme as a Pyroptosis Inhibitor Alleviates Neurodegeneration.普鲁士蓝纳米酶作为一种焦亡抑制剂可减轻神经退行性变。
Adv Mater. 2022 Apr;34(15):e2106723. doi: 10.1002/adma.202106723. Epub 2022 Mar 1.
2
Novel Targets and Therapeutic Strategies to Protect Against Hepatic Ischemia Reperfusion Injury.预防肝脏缺血再灌注损伤的新靶点与治疗策略
Front Med (Lausanne). 2022 Jan 4;8:757336. doi: 10.3389/fmed.2021.757336. eCollection 2021.
3
New Insights in Mechanisms and Therapeutics for Short- and Long-Term Impacts of Hepatic Ischemia Reperfusion Injury Post Liver Transplantation.
Investigation into recent advanced strategies of reactive oxygen species-mediated therapy based on Prussian blue: Conceptualization and prospect.
基于普鲁士蓝的活性氧介导疗法近期先进策略的研究:概念化与展望
Bioact Mater. 2025 Feb 13;48:71-99. doi: 10.1016/j.bioactmat.2025.01.023. eCollection 2025 Jun.
4
Clinical prognostic value of TREM1 in patients with liver cancer lung metastasis.TREM1在肝癌肺转移患者中的临床预后价值
Transl Cancer Res. 2024 Oct 31;13(10):5446-5457. doi: 10.21037/tcr-24-492. Epub 2024 Oct 29.
5
Prussian blue nanotechnology in the treatment of spinal cord injury: application and challenges.普鲁士蓝纳米技术在脊髓损伤治疗中的应用与挑战
Front Bioeng Biotechnol. 2024 Sep 11;12:1474711. doi: 10.3389/fbioe.2024.1474711. eCollection 2024.
6
Lactobacillus reuteri mitigates hepatic ischemia/reperfusion injury by modulating gut microbiota and metabolism through the Nrf2/HO-1 signaling.罗伊氏乳杆菌通过 Nrf2/HO-1 信号通路调节肠道微生物群和代谢减轻肝缺血/再灌注损伤。
Biol Direct. 2024 Mar 18;19(1):23. doi: 10.1186/s13062-024-00462-5.
7
Reactive Oxygen Species Scavenging Nanozymes: Emerging Therapeutics for Acute Liver Injury Alleviation.活性氧物种清除纳米酶:急性肝损伤缓解的新兴治疗策略。
Int J Nanomedicine. 2023 Dec 22;18:7901-7922. doi: 10.2147/IJN.S435544. eCollection 2023.
8
Reactive oxygen species (ROS) scavenging biomaterials for anti-inflammatory diseases: from mechanism to therapy.用于抗炎疾病的活性氧 (ROS) 清除生物材料:从机制到治疗。
J Hematol Oncol. 2023 Nov 30;16(1):116. doi: 10.1186/s13045-023-01512-7.
9
Optimizing the Composition of the Substrate Enhances the Performance of Peroxidase-like Nanozymes in Colorimetric Assays: A Case Study of Prussian Blue and 3,3'-Diaminobenzidine.优化底物组成可增强过氧化物酶样纳米酶在比色分析中的性能:普鲁士蓝和 3,3'-二氨基联苯胺的案例研究。
Molecules. 2023 Nov 16;28(22):7622. doi: 10.3390/molecules28227622.
10
Non-coding RNAs: The potential biomarker or therapeutic target in hepatic ischemia-reperfusion injury.非编码 RNA:肝缺血再灌注损伤的潜在生物标志物或治疗靶点。
World J Gastroenterol. 2023 Sep 7;29(33):4927-4941. doi: 10.3748/wjg.v29.i33.4927.
肝移植术后肝缺血再灌注损伤的短期和长期影响的机制和治疗的新见解。
Int J Mol Sci. 2021 Jul 30;22(15):8210. doi: 10.3390/ijms22158210.
4
How Machine Perfusion Ameliorates Hepatic Ischaemia Reperfusion Injury.机器灌注如何改善肝脏缺血再灌注损伤。
Int J Mol Sci. 2021 Jul 14;22(14):7523. doi: 10.3390/ijms22147523.
5
Hemorheological and Microcirculatory Factors in Liver Ischemia-Reperfusion Injury-An Update on Pathophysiology, Molecular Mechanisms and Protective Strategies.肝缺血再灌注损伤中的血液流变学和微循环因素:病理生理学、分子机制和保护策略的最新进展。
Int J Mol Sci. 2021 Feb 13;22(4):1864. doi: 10.3390/ijms22041864.
6
Drug delivery nanosystems targeted to hepatic ischemia and reperfusion injury.靶向肝缺血再灌注损伤的药物递送纳米系统
Drug Deliv Transl Res. 2021 Apr;11(2):397-410. doi: 10.1007/s13346-021-00915-8. Epub 2021 Mar 3.
7
Prussian blue nanozyme-mediated nanoscavenger ameliorates acute pancreatitis via inhibiting TLRs/NF-κB signaling pathway.普鲁士蓝纳米酶介导电纳米清除剂通过抑制 TLRs/NF-κB 信号通路改善急性胰腺炎。
Theranostics. 2021 Jan 1;11(7):3213-3228. doi: 10.7150/thno.52010. eCollection 2021.
8
Neutrophil-like Cell-Membrane-Coated Nanozyme Therapy for Ischemic Brain Damage and Long-Term Neurological Functional Recovery.中性粒细胞样细胞膜包被纳米酶疗法治疗缺血性脑损伤及长期神经功能恢复
ACS Nano. 2021 Feb 23;15(2):2263-2280. doi: 10.1021/acsnano.0c07973. Epub 2021 Jan 11.
9
Antioxidant and anti-inflammatory activities of Prussian blue nanozyme promotes full-thickness skin wound healing.普鲁士蓝纳米酶的抗氧化和抗炎活性促进全层皮肤伤口愈合。
Mater Sci Eng C Mater Biol Appl. 2021 Feb;119:111596. doi: 10.1016/j.msec.2020.111596. Epub 2020 Oct 8.
10
Prussian blue nanoparticles: synthesis, surface modification, and biomedical applications.普鲁士蓝纳米颗粒:合成、表面修饰及生物医学应用。
Drug Discov Today. 2020 Aug;25(8):1431-1443. doi: 10.1016/j.drudis.2020.05.014. Epub 2020 May 31.